… β-Lactam resistance among clinical isolates is a growing problem, and the identification of …
other emerging β-lactamases will soon be imperative for clinical microbiology laboratories (2, …

… Committee for Clinical Laboratory … βlactams arises from plasmid acquisition of a
normally chromosomal ampC gene. In addition to oxyimino-β-lactam resistance, AmpC β-lactamase …

… in Korea, 7,8 there has been no surveillance for class A or D β-lactamases in P. aeruginosa.
… β-lactamases and their extended-spectrum derivatives in clinical isolates of P. aeruginosa. …

… detected in a Klebsiella pneumoniae clinical isolate from Vietnam (5). It … The VEB-1 β-lactamase
was identified recently in an … The VEB-1 β-lactamase confers a higher level of resistance …

We examined the prevalence of extended-spectrum β-lactamase (ESBL)-producing strains
of Klebsiella pneumoniae, Klebsiella oxytoca, Escherichia coli, Proteus mirabilis, Citrobacter …

… a multidrug-resistant Pseudomonas aeruginosa clinical isolate (FI-14/157) … clinical isolate
underscores the increasing diversity of such enzymes that can be encountered in the clinical …

… bullet” β-lactam-β-lactamase inhibitor combination that targets all clinically important β-lactamases
(eg, … This debated question is addressed and the novel β-lactam-β-lactamase inhibitor …

… Novel plasmid-mediated 1-lactamase in clinical isolates of Klebsiella pneumoniae more
resistant to ceftazidime than to other broad-spectrum cephalosporins. Antimicrob. Agents …

… -β-lactamases (MBLs) produced by isolates of Pseudomonas aeruginosa were investigated.
During 2001, 506 nonduplicate isolates … in clinical isolates of P. aeruginosa at our Institution. …

… We investigate the dissemination of CTX-M enzymes among clinical isolates of Escherichia
coli recovered in … We describe the phenotypes and genetic characteristics of these isolates. …